688051-07-2

Basic information

• Product Name: CHEMBRDG-BB 6018456
• Synonyms: N-(3-Hydroxyphenyl)-5-Methylisoxazole-3-carboxaMide;CHEMBRDG-BB 6018456;N-(3-HYDROXYPHENYL)-5-METHYL-3-ISOXAZOLECARBOXAMIDE;UKRORGSYN-BB BBV-188391;N-(3-hydroxyphenyl)-5-methyl-3-isoxazolecarboxamide(SALTDATA: FREE)
• CAS NO: 688051-07-2
• Molecular Formula: C11H10N2O3
• Molecular Weight: 218.21
• Mol File: 688051-07-2.mol

Chemical Properties

• Boiling Point: 342.9°C at 760 mmHg
• Flash Point: 161.2°C
• Appearance: /
• Density: 1.372g/cm³
• Vapor Pressure: 3.68E-05mmHg at 25°C
• Refractive Index: 1.648
• Storage Temp.: 2-8°C
• CAS DataBase Reference: CHEMBRDG-BB 6018456(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMBRDG-BB 6018456(688051-07-2)
• EPA Substance Registry System: CHEMBRDG-BB 6018456(688051-07-2)

Safety Data

• Hazardous Substances Data: 688051-07-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
CHEMBRDG-BB 6018456 is used as a potential therapeutic agent for cardiovascular diseases due to its antiplatelet activity, which helps in the treatment and management of conditions such as atherosclerosis, hypertension, and myocardial infarction.
Used in Anticoagulant Therapy:
CHEMBRDG-BB 6018456 is used as an anticoagulant to prevent blood clot formation, reducing the risk of thrombotic events such as deep vein thrombosis, pulmonary embolism, and stroke.
Used in Antioxidant and Anti-inflammatory Applications:
CHEMBRDG-BB 6018456 is used as a potential treatment for diseases characterized by oxidative stress and inflammation, such as neurodegenerative disorders, autoimmune diseases, and chronic inflammatory conditions. Its antioxidant and anti-inflammatory properties help in mitigating the harmful effects of reactive oxygen species and reducing inflammation.
Used in Drug Development:
CHEMBRDG-BB 6018456 serves as a lead compound in drug development for various therapeutic applications, including cardiovascular diseases, anticoagulant therapy, and conditions involving oxidative stress and inflammation. Its unique properties and potential effects make it a valuable candidate for further research and development in the pharmaceutical industry.

InChI:InChI=1/C11H10N2O3/c1-7-5-10(13-16-7)11(15)12-8-3-2-4-9(14)6-8/h2-6,14H,1H3,(H,12,15)

Relevant articles and documents

The new compound and its in the treatment of inflammation or inflammation-related application (by machine translation)

The present invention provides novel compounds and their use in the treatment of inflammation or inflammation-related diseases of application, in particular, the invention synthesizes a series of UTLOH compound, the compound can be effectively inhibit LPS-induced PGE2 and NO level, but also can be effective for the treatment of inflammation or inflammation-related disease, particularly for the treatment of Gout, analgesic and anti-inflammatory related diseases. (by machine translation)

Isoxazole derivatives and methods of treating nitric oxide mediated diseases

A series of isoxazole derivatives and methods of suppressing, inhibiting, or preventing disorders mediated by nitric oxide (NO) and/or proinflammatory cytokines, such as TNF-α (tumor necrosis factor alpha), IL-1 (interlukin-1), and IL-6, are described.